Abstract
The effect of monoterpene perillyl alcohol (POH) on cell growth, cell cycle progression, and expression of cell cycle-regulatory proteins in estrogen receptor (ER)-positive (KPL-1 and MCF-7) and ER-negative (MKL-F and MDA-MB-231) human breast cancer cell lines was examined. POH inhibited cell proliferation in a dose-dependent manner in all cell lines tested. POH at a dose of 500 µM had a cytostatic effect, in which growth inhibition was due to accumulation of cells in G1-phase. Cell cycle progression was preceded by a decrease in G1 cyclins (cyclin D1 and E), followed by an increase in p21Cip1/Waf1 and a decrease in proliferating cell nuclear antigen level. Levels of p53 and cyclin A were unchanged. POH at a dose of 75 mg/kg administered intraperitoneally three times a week throughout the entire 6-week experimental period suppressed orthotopically transplanted KPL-1 tumor cell growth and regional lymph node metastasis in a nude mouse system. POH inhibited both ER-positive and -negative human breast cancer cell growth in vitro, and suppressed growth and metastasis in vivo.
Similar content being viewed by others
References
Crowell PL, Siar Ayoubi A, Burke YD: Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer. Adv Exp Med Biol 401: 131–136, 1996
Elegbede JA, Elson CE, Qureshi A, Tanner MA, Gould MN: Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis 5: 661–664, 1984
Elson CE, Maltzman TH, Boston JL, Tanner MA, Gould MN: Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis. Carcinogenesis 9: 331–332, 1988
Maltzman TH, Hurt LH, Elson CE, Tanner MA, Gould MN: The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil. Carcinogenesis 10: 781–783, 1989
Gould MN: Prevention and therapy of mammary cancer by monoterpenes. J Cell Biochem Suppl 22: 139–144, 1995
Haag JD, Lindstrom MJ, Gould MN: Limonene-induced regression of mammary carcinomas. Cancer Res 52: 4021–4026, 1992
Simonsen JL, Owen LN: The Terpenes. Vol. 1, Cambridge University Press, London, 1953
Haag JD, Gould MN: Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother Pharmacol 34: 477–483, 1994
Crowell PL: Monoterpenes in breast cancer chemoprevention. Breast Cancer Res Treat 46: 191–197, 1997
Lantry LE, Zhang Z, Gao F, Crist KA, Wang Y, Kelloff GJ, Lubet RA, You M: Chemopreventive effect of perillyl alcohol on 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung. J Cell Biochem Suppl 27: 20–25, 1997
Reddy BS, Wang CX, Samaha H, Lubet R, Steele VE, Kelloff GJ, Rao CV: Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 57: 420–425, 1997
Mills JJ, Chari RS, Boyer IJ, Gould MN, Jirtle RL: Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res 55: 979–983, 1995
Stark MJ, Burke YD, McKinzie JH, Ayoubi AS, Crowell PL: Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett 96: 15–21, 1995
Belanger JT: Perillyl alcohol: applications in oncology. Altern Med Rev 3: 448–457, 1998
Shi W, Gould MN: Induction of cytostasis in mammary carcinoma cells treated with the anticancer agent perillyl alcohol. Carcinogenesis 23: 131–142, 2002
Bardon S, Picard K, Martel P: Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 expression in human breast cancer cell lines. Nutr Cancer 32: 1–7, 1998
Ariazi EA, Satomi Y, Ellis MJ, Haag JD, Shi W, Sattler CA, Gould MN: Activation of the transforming growth factor â signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. Cancer Res 59: 1917–1928, 1999
Crowell PL, Chang RR, Ren Z, Elson CE, Gould MN: Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem 266: 17679–17685, 1991
Kurebayashi J, Kurosumi M, Sonoo H: A new human breast cancer cell line, KPL-1, secretes tumor-associated antigens and grows rapidly in female athymic nude mice. Br J Cancer 71: 845–853, 1995
Soule HD, Vazguez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409–1416, 1973
McLeskey SW, Zhang L, Kharbanda S, Kurebayashi J, Lippma ME, Dickson RB, Kern FG: Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis. Breast Cancer Res Treat 39: 103–117, 1996
Cailleau R, Young R, Olive M, Reeves Jr WJ: Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53: 661–674, 1974
Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936–942, 1987
Geran RI, Greenberg NH, MacDonald MM, Schumacher AM, Abbott BJ: Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep 3: 1–103, 1972
Labat-Moleur F, Guillermet C, Lorimier P, Robert C, Lantuejoul S, Brambilla E, Negoescu A: TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement. J Histochem Cytochem 46: 327–334, 1998
Ripple GH, Gould MN, Arzoomanian RZ, Alberti D, Feierabend C, Simon K, Binger K, Tutsch KD, Pomplun M, Wahamaki A, Marnocha R, Wilding G, Bailey HH: Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. Clin Cancer Res 6: 390–396, 2000
Sherr CJ: G1 phase progression: cyclin on cue. Cell 79: 551–555, 1994
Jacks T, Weinberg RA: Cell-cycle control and its watchman. Nature 381: 643–644, 1996
Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501–1512, 1999
Cayrol C, Knibiehler M, Ducommun B: p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16: 311–320, 1998
Pagano M, Pepperkok R, Verde F, AnsorgeW, Draetta G: Cyclin A is required at two points in the human cell cycle. EMBO J 11: 961–971, 1992
Bardon S, Foussard V, Fournel S, Loubat A: Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett 181: 187–194, 2002
Lluria-Prevatt M, Morreale J, Gregus J, Alberts DS, Kaper F, Giaccia A, Powell MB: Effects of perillyl alcohol on melanoma in the TPras mouse model. Cancer Epidemiol Biomarkers Prev 11: 573–579, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yuri, T., Danbara, N., Tsujita-Kyutoku, M. et al. Perillyl Alcohol Inhibits Human Breast Cancer Cell Growth in vitro and in vivo . Breast Cancer Res Treat 84, 251–260 (2004). https://doi.org/10.1023/B:BREA.0000019966.97011.4d
Issue Date:
DOI: https://doi.org/10.1023/B:BREA.0000019966.97011.4d